Weighing the cons and pros: Women's reasons for discontinuing hormone replacement therapy

Health Care for Woman International

Volumn 23, Issue 1, 2002, Pages 19-32

  McClennan Reece, Susan ^a,b  

^a UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DECISION MAKING; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HUMAN; INTERVIEW; MENOPAUSE; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; TREATMENT REFUSAL; UTILIZATION REVIEW;

ADULT; AGED; DECISION MAKING; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INTERVIEWS; MENOPAUSE; MIDDLE AGED; TREATMENT REFUSAL;

EID: 0036369672     PISSN: 07399332     EISSN: None     Source Type: Journal    
DOI: 10.1080/073993302753428401     Document Type: Article

References (40)

1. Achieving long-term continuance of menopausal ERT/HRT: Consensus Opinion of the North American Menopause Society. (1998). Menopause, 5, 69-76.
2. Berman, R. S., Epstein, R. S., & Lydick, E. G. (1996). Compliance of women in taking estrogen replacment therapy. Journal of Women's Health, 5, 213-220.
3. Brinton, L. A., & Schairer, C. (1997). Postmenopausal hormone replacement therapy - Time for a reappraisal? The New England Journal of Medicine, 336, 1821-1822.
4. Bywaters, P., & Bond, M. (1997). Rethinking the concept of compliance: Making decisions about hormone replacement therapy. Social Sciences in Health, 3, 73-82.
5. Cagnacci, A., Volpe, A., Arangino, S., Malmusi, S., Draetta, F. P., Matteo, M. L., Maschio, E., Vacca, A. M. B., & Melis, G. B. (1997). Depression and anxiety in climacteric women: Role of hormone replacement therapy. Menopause, 4, 206-211.
6. Col, N. F., Eckman, M. H., Karas, R. H., Pauker, S. G., Goldberg, R. J., Ross, E. M., Orr, R. K., & Wong, J. B. (1997). Patient-specific decisions about hormone replacement therapy in postmenopausal women. Journal of the American Medical Association, 277, 1040-1047.
7. Coope, J., & Marsh, J. (1992). Can we improve compliance with long-term HRT? Maturitas, 15, 151-158.
8. Crabtree, B. F., & Miller, W. L. (1991). A qualitative approach to primary care research: The long interview. Family Medicine, 23, 145-151.
9. Ettinger, B., Quesenberry, C., Schroeder, D. A., & Friedman, G. (1997). Longterm postmenopausal estrogen therapy may be associated with increased risk of breast cancer: A cohort study. Menopause, 4, 125-129.
10. Evans, M. P., Fleming, K. C., & Evans, J. M. (1995). Hormone replacement therapy: Management of common problems. Mayo Clinic Proceedings, 70, 800-805.
11. Faulkner, D. L., Young, C., Hutchins, D., & Schwed McCollam, J. (1998). Patient noncompliance with hormone replacement therapy: A nationwide estimate using a large perscription claims database. Menopause, 5, 226-229.
12. Felson, D. T., Zhang, Y., Aannan, M. T., Kiel, D. P., Wilson, P. W. F., & Anderson, J. J. (1993). The effect of postmenopausal estrogen therapy on bone-density in elderly women. New England Journal of Medicine, 329, 1141-1146.
13. Garton, M., Reid, D., & Rennie, E. (1995). The climacteric, osteoporosis, and hormone replacement: Views of women aged 45-49. Maturitas, 21, 7-15.
14. Grodstein, F., Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Joffe, M., Rosner, B., Fuchs, C. Hankinson, S. E., Hunter, D. J., Hennekens, C. H., & Speizer, F. E. (1997). Postmenopausal hormone therapy and mortality. The New England Journal of Medicine, 336, 1769-1775.
15. Hosking, D., Chilvers, C. E. D., Christiansen, C., Rfavn, P., Wasnich, R., Ross, P., McClung, M., Balske, A., Thompson, D., Daley, M., & Yates, A. J. (1998). Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. The New England Journal of Medicine, 338, 485-492.
16. Hunter, M. S., O'Dea, I., & Britten, N. (1997). Decision-making and hormone replacement therapy: A qualitative analysis. Social Science and Medicine, 45, 1541-1548.
17. Johannes, C. B., Crawford S. L., Posner, J. G., & McKinlay, S. M. (1994). Longitudinal patterns and correlates of hormone replacment therapy use in middle-aged women. American Journal of Epidemiology, 140, 439-452.
18. Limouzin-Lamothe, M. A., Mairon, N., Joyce, C., & Le Gal, M. (1994). Quality of life after menopause: Influence of hormonal replacement therapy. American Journal of Obstetrics and Gynecology, 170, 618-624.
19. Logothetis, M. L. (1991). Women's decisions about estrogen replacement therapy. Western Journal of Nursing Research, 13, 458-474.
20. Mansfield, P. K., & Voda, A. M. (1996). Woman-centered information on menopause for health care providers: Findings from the midlife women's health survey. Health Care for Women International, 18, 55-72.
21. Manson, J. E. (1994). Postmenopausal hormone therapy and atherosclerotic disease. American Heart Journal, 128, 1337-1343.
22. Miller, W. L., & Crabtree, B. F. (1992). Primary care research: A multimethod and typology and qualitative road map. In B. F. Crabtree & W. L. Miller, Doing qualitative research (pp. 3-28). Newbury Park, CA: Sage.
23. Nachtigall, L. E. (1990). Enhancing patient compliance with HRT at menopause. Obstetrics and Gynecology, 75, 775-805.
24. Newton, K. E. M., La Croix, A. Z., Leveille, S. G., Rutter, C., Keenan, N. L., & Anderson, L. A. (1997). Women's beliefs and decisions about hormone replacement therapy. Journal of Women's Health, 6, 459-465.
25. Padonu, G., Holmes-Rovner, M., Rothert, M., Schmitt, N., Kroll, J., Rovner, D., Talarczyk, G., Breer, L., Ransom, S., & Gladney, E. (1996). African-American women's perceptions of menopause. American Journal of Health Behavior, 20, 242-251.
26. Rabin, D. S., Cipparrone, N., Linn, E. S., & Moen, M. (1999). Why menopausal women do not want to take hormone replacement therapy. Menopause, 6, 61-67.
27. Reynolds, R. F., Obermeyer, C. M., Walker, A. M., & Guilbert, D. (2001). Side effects and sociobehavioral factors associated with the discontinuation of hormone therapy in a Massachusetts health maintenance organization. Menopause, 8(3), 189-199.
28. Rothert, M., Rovner, D., Holmes, M., Schmitt, N., Talarczyk, G., Kroll, J., & Gogate, J. (1990). Women's use of information regarding hormone replacement therapy. Research in Nursing & Health, 13, 355-366.
29. Rozenberg, S., Kroll, M., & Vandromme, J. (1996). Decision factors influencing hormone replacement therapy. British Journal of Obstetrics and Gynaecology, 99(13) Supplement, 325-328.
30. Ryan, P. J., Harrison, R., Blake, G. M., & Fogelman, I. (1992). Compliance with hormone replacement therapy (HRT) after screening for postmenopausal osteoporosis. British Journal of Obstetrics and Gynaecology, 99, 325-328.
31. Sandelowski, M. (1995a). Qualitative analysis: What it is and how to begin. Research in Nursing & Health, 18, 371-375.
32. Sandelowski, M. (1995b). Sample size in qualitative research. Research in Nursing and Health, 18, 179-183.
33. Sherwin, B. B. (1996). Hormones, mood, and cognitive functioning in postmenopausal women. Obstetrics & Gynecology, 87(2), Supplement, 20S-26S.
34. Sherwin, B. B. (1997). Estrogen effects on cognition in menopausal women. Neurology, 48(7) Supplement, S21-S26.
35. Sherwin, B. B. (1998). Estrogen and cognitive functioning in women. Proceedings of the Society for Experimental Biology and Medicine, 217, 17-22.
36. Thorne, S., Kirkham, S. R., & MacDonald-Emes, J. (1997). Interpretive description: A noncategorical qualitative alternative for developing nursing knowlege. Research in Nursing & Health, 20, 169-177.
37. U.S. Bureau of the Census. (1999). Population projections of the United States by age, sex, race, and Hispanic origin: 1995 to 2050. Current Population Reports, Series P25-1130.
38. Utian, W. H., & Schiff, I. (1994). North American Menopause Society - Gallop survey on women's knowledge, information sources, and attitudes to menopause and hormone replacement therapy. Menopause, 1, 39-48.
39. Woods, N. F., Falk, S., Saver, B., Taylor, T. R., Stevens, N., & MacLaren, A. (1998). Deciding about hormone therapy: Validation of a model. Menopause, 5, 52-59.
40. Woods, N. F., Sauer, B., & Taylor, T. (1998). Attitudes toward menopause and hormone therapy among women with access to care. Menopause, 5, 178-188.